Mark Ragosa, CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 17,845 shares at $42.85 ($772K) on 2026-02-09, disclosed to the SEC on 2026-02-11.
Open-market sale of $772k KNSA by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.85 | 9,114 | $391K | 50.6% |
| 2 | $43.72 | 8,731 | $382K | 49.4% |
| Total | $43.28 avg | 17,845 | $772K | 100% |
| Filing → |
| KNSA | SELL | 2025-12-10 | $3.6M | — | Filing → |
| KNSA | SELL | 2025-11-14 | $815K | — | Filing → |
| KNSA | SELL | 2025-10-30 | $4K | — | Filing → |